These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 1505141)

  • 21. Novel approaches to the endocrine therapy of breast cancer.
    Dowsett M
    Eur J Cancer; 1990; 26(9):989-92. PubMed ID: 1980589
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions of antioestrogens and aromatase inhibitors.
    Schmid P; Possinger K
    Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
    Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
    Buzdar A; Douma J; Davidson N; Elledge R; Morgan M; Smith R; Porter L; Nabholtz J; Xiang X; Brady C
    J Clin Oncol; 2001 Jul; 19(14):3357-66. PubMed ID: 11454883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effects of anti-estrogenic drugs.
    Ray A; Ficek M
    Acta Pharm; 2012 Jun; 62(2):141-55. PubMed ID: 22750814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone therapy in advanced breast carcinoma: present and future trends.
    Bajetta E; Zilembo N; Di Leo A; Buzzoni R; Zampino MG; Biganzoli L; Noberasco C
    Cancer Treat Rev; 1994 Jul; 20(3):241-58. PubMed ID: 8020005
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
    de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
    Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Endocrine therapy for advanced or recurrent breast cancer].
    Sonoo H; Kurebayashi J
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):909-16. PubMed ID: 11478139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Kauppila A
    Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging role of aromatase inhibitors in the treatment of breast cancer.
    Harvey HA
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Developments in endocrine therapy for breast cancer].
    Matsui A; Ikeda T; Jinno H; Tajima G; Hohjou T; Tokura H; Mitsui Y; Asaga S; Muto T; Kitajima M
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1138-45. PubMed ID: 12145993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Megestrol acetate as hormone therapy in oncology].
    Berstein LM
    Vopr Onkol; 1998; 44(2):142-8. PubMed ID: 9615815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aromatase inhibitors].
    Feutrie ML; Bonneterre J
    Bull Cancer; 1999 Oct; 86(10):821-7. PubMed ID: 10572233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current controversies in the endocrine therapy of advanced breast cancer.
    Powles TJ
    Oncology; 1992; 49 Suppl 2():18-21. PubMed ID: 1461621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects and mechanism of action of antiestrogens in breast cancer].
    Borgna JL; Rochefort H
    Sem Hop; 1984 Mar; 60(10):703-9. PubMed ID: 6322320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study.
    Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Caroti C; Farris A; Cruciani G; Villa E; Schieppati G; Mustacchi G;
    J Clin Oncol; 2001 Nov; 19(22):4209-15. PubMed ID: 11709564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.